Agilent Technologies (NYSE:A) Releases Q3 Earnings Guidance

Agilent Technologies (NYSE:AGet Rating) updated its third quarter earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $1.20-1.22 for the period, compared to the consensus estimate of $1.20. The company issued revenue guidance of $1.625-1.650 billion, compared to the consensus revenue estimate of $1.66 billion.Agilent Technologies also updated its FY 2022 guidance to $4.86-$4.93 EPS.

A number of research analysts have issued reports on the stock. Wells Fargo & Company decreased their price target on shares of Agilent Technologies from $160.00 to $130.00 and set an equal weight rating for the company in a report on Monday, April 25th. Stifel Nicolaus decreased their price target on shares of Agilent Technologies from $169.00 to $145.00 and set a hold rating for the company in a report on Wednesday, February 23rd. Truist Financial cut shares of Agilent Technologies from a buy rating to a hold rating in a report on Tuesday, April 19th. Bank of America decreased their price target on shares of Agilent Technologies from $179.00 to $160.00 and set a buy rating for the company in a report on Wednesday, February 23rd. Finally, SVB Leerink decreased their price target on shares of Agilent Technologies from $175.00 to $145.00 and set an outperform rating for the company in a report on Wednesday, February 23rd. Three investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of Buy and an average target price of $163.08.

A traded down $1.57 during midday trading on Tuesday, hitting $124.41. 2,149,569 shares of the company traded hands, compared to its average volume of 2,088,196. The company has a current ratio of 2.19, a quick ratio of 1.64 and a debt-to-equity ratio of 0.53. The company has a market capitalization of $37.37 billion, a price-to-earnings ratio of 31.58, a PEG ratio of 2.80 and a beta of 1.06. Agilent Technologies has a 52-week low of $112.64 and a 52-week high of $179.57. The business has a 50 day simple moving average of $127.21 and a two-hundred day simple moving average of $139.27.

Agilent Technologies (NYSE:AGet Rating) last posted its quarterly earnings data on Tuesday, May 24th. The medical research company reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.12 by $0.01. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.62 billion. Agilent Technologies had a net margin of 18.70% and a return on equity of 27.04%. The company’s revenue was up 5.4% compared to the same quarter last year. During the same period last year, the firm posted $0.97 earnings per share. Equities research analysts anticipate that Agilent Technologies will post 4.86 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 27th. Shareholders of record on Tuesday, July 5th will be issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 0.68%. The ex-dividend date of this dividend is Friday, July 1st. Agilent Technologies’s payout ratio is 21.32%.

In other news, SVP Michael Tang sold 1,210 shares of the firm’s stock in a transaction dated Friday, March 18th. The shares were sold at an average price of $136.21, for a total value of $164,814.10. The transaction was disclosed in a filing with the SEC, which is available through this link.

Large investors have recently bought and sold shares of the company. Ironwood Wealth Management LLC. raised its stake in Agilent Technologies by 142.5% during the second quarter. Ironwood Wealth Management LLC. now owns 485 shares of the medical research company’s stock worth $72,000 after purchasing an additional 285 shares during the period. Penserra Capital Management LLC purchased a new position in Agilent Technologies during the first quarter worth about $60,000. EverSource Wealth Advisors LLC purchased a new position in Agilent Technologies during the fourth quarter worth about $31,000. Belpointe Asset Management LLC raised its stake in Agilent Technologies by 30.0% during the fourth quarter. Belpointe Asset Management LLC now owns 1,944 shares of the medical research company’s stock worth $310,000 after purchasing an additional 449 shares during the period. Finally, Sequoia Financial Advisors LLC raised its stake in Agilent Technologies by 52.1% during the first quarter. Sequoia Financial Advisors LLC now owns 2,334 shares of the medical research company’s stock worth $309,000 after purchasing an additional 799 shares during the period.

Agilent Technologies Company Profile (Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Recommended Stories

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.